{"schema_version":"1.0","canonical_url":"https://patentable.app/patents/US-11494900","patent":{"patent_number":"US-11494900","title":"Prognosis of prostate cancer with computerized histomorphometric features of tumor morphology from routine hematoxylin and eosin slides","assignee":null,"inventors":[],"filing_date":"2019-12-30T00:00:00.000Z","publication_date":"2022-11-08T00:00:00.000Z","cpc_codes":["G06T","A61B","G06F","G06F","G06N","G06N","G06T","G06T","G06V","G06V","G16H","G16H","G16H","G16H","G16H","G16H","G16H","G06T","G06T","G06T","G06T","G06T","G06T"],"num_claims":27,"abstract":"Embodiments facilitate generating a biochemical recurrence (BCR) prognosis by accessing a digitized image of a region of tissue demonstrating prostate cancer (CaP) pathology associated with a patient; generating a set of segmented gland lumen by segmenting a plurality of gland lumen represented in the region of tissue using a deep learning segmentation model; generating a set of post-processed segmented gland lumen; extracting a set of quantitative histomorphometry (QH) features from the digitized image based, at least in part, on the set of post-processed segmented gland lumen; generating a feature vector based on the set of QH features; computing a histotyping risk score based on a weighted sum of the feature vector; generating a classification of the patient as BCR high-risk or BCR low-risk based on the histotyping risk score and a risk score threshold; generating a BCR prognosis based on the classification; and displaying the BCR prognosis."},"analysis":{"summary":null,"layman_explanation":null,"technical_analysis":null,"business_analysis":null,"faqs":null,"topics":[],"tech_cluster":null},"seo":{"title":"Prognosis of prostate cancer with computerized histomorphometric features of tumor morphology from routine hematoxylin and eosin slides","description":"Embodiments facilitate generating a biochemical recurrence (BCR) prognosis by accessing a digitized image of a region of tissue demonstrating prostate cancer (CaP) pathology associated with a patient;","keywords":[]},"attribution":{"source":"Patentable","source_url":"https://patentable.app","canonical_url":"https://patentable.app/patents/US-11494900","license":"CC-BY-4.0-like","license_terms":"AI-generated analysis on this page (summary, layman_explanation, technical_analysis, business_analysis, faqs) may be reused with attribution and a visible link back to the canonical URL above. Patent abstracts, claims, and bibliographic data are USPTO public domain.","required_link":"https://patentable.app/patents/US-11494900","citation_suggestion":"Patentable. \"Prognosis of prostate cancer with computerized histomorphometric features of tumor morphology from routine hematoxylin and eosin slides\" (US-11494900). https://patentable.app/patents/US-11494900","copyright_holder":"Nomic Interactive Technology LLC"},"links":{"html":"https://patentable.app/patents/US-11494900","json":"https://patentable.app/api/llm-context/US-11494900","site":"https://patentable.app","llms_txt":"https://patentable.app/llms.txt"},"generated_at":"2026-05-31T00:36:54.185Z"}